CDC Planning Guidelines for Genetic Testing Labs | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Centers for Disease Control and Prevention is currently developing guidelines for labs that provide biochemical genetic testing (BGT) and newborn screening (NBS) for inherited metabolic disorders, as well as broader guidelines for molecular genetic testing (MGT), a CDC representative told the Secretary's Advisory Committee on Genetics, Health, and Society on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.